Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
STAT12d
Pharmalittle: We’re reading about tariffs’ effect on drug costs, a scrapped vaccine plant expansion, and more
This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...
GazetteXtra22h
Bill to cap prescription drug costs introduced in US Senate
Sen. Tammy Baldwin of Wisconsin and other Democrats in the U.S. Senate on Friday introduced new legislation to cap ...
Gillibrand proposes new bill to lower prescription drug prices
Washington — Senator Kirsten Gillibrand announced new legislation that would, as she says, make prescription drugs more ...
USA Today8d
Trump scrapping lower prescription drug price plan will hurt fellow seniors | Editorial
This one, an idea that will keep drug prices high and hurt healthcare, deserves a revision, too. Medicare is the federal government program that provides health coverage for people 65 years and ...
Trump tariffs could raise medication costs and exacerbate shortages
AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...
WNYT NewsChannel 133d
Gillibrand seeks to cap out-of-pocket drug costs
U.S. Sen. Kirsten Gillibrand is proposing legislation to reduce the cost of prescription drugs. The Capping Prescription Costs Act legislation would cap the annual out-of-pocket cost of ...